Page last updated: 2024-09-04

vatalanib and u 0126

vatalanib has been researched along with u 0126 in 2 studies

Compound Research Comparison

Studies (vatalanib)	Trials (vatalanib)	Recent Studies (post-2010) (vatalanib)	Studies (u 0126)	Trials (u 0126)	Recent Studies (post-2010) (u 0126)
276	42	98	2,816	2	1,213

Protein Interaction Comparison

Protein	Taxonomy	u 0126 (IC50)
RAF proto-oncogene serine/threonine-protein kinase	Homo sapiens (human)	0.29
Serine/threonine-protein kinase B-raf	Homo sapiens (human)	0.25
Amine oxidase [flavin-containing] B	Rattus norvegicus (Norway rat)	0.07
Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens (human)	0.2816
Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens (human)	0.2529

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Al-Mazaideh, GM; Erdmann, F; Göllner, C; Rohe, A; Schmidt, M; Sippl, W; Wichapong, K	1

Other Studies

2 other study(ies) available for vatalanib and u 0126

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay. European journal of medicinal chemistry, 2013, Volume: 61 Topics: Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glycolipids; Humans; Membrane Proteins; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship	2013

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007

Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.

European journal of medicinal chemistry, 2013, Volume: 61

Topics: Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glycolipids; Humans; Membrane Proteins; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship

2013